{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:25:10Z","timestamp":1788942310254,"version":"build-2803163510"},"reference-count":154,"publisher":"Wiley","issue":"S7","license":[{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Since the publication of the Australian consensus guidelines in 2011, the routine use of prophylactic antibiotics in patients with neutropenia has remained controversial, because of concern that the risks of promoting antimicrobial resistance outweighed the level of evidence that their use reduced mortality. Populations at risk have changed over this period and now include a multitude of new cancer therapies, such as targeted cancer therapies and immunotherapies. Emerging understanding about the importance and role of the microbiome in defining treatment response and patterns of antibiotic resistance has also expanded. In addition, the management of neutropenic fever has improved significantly through the development and routine implementation of sepsis pathways. These updated consensus guidelines review recent evidence for the use of antibacterial prophylaxis in adults and children receiving cancer therapies associated with neutropenia. Recommendations presented in these guidelines were based on evaluating current evidence for the benefits and harms of antibacterial prophylaxis while considering the current Australian and New Zealand healthcare setting. In most circumstances, the potential harm of antibiotic resistance, adverse effects of antibiotics and disruption to the microbiome, outweighed the benefit of reducing the incidence of infection, without a benefit in mortality.<\/jats:p>","DOI":"10.1111\/imj.70250","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T04:35:54Z","timestamp":1768192554000},"page":"115-135","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Consensus guidelines for antibacterial prophylaxis in patients with neutropenia"],"prefix":"10.1111","volume":"55","author":[{"given":"Julian","family":"Lindsay","sequence":"first","affiliation":[{"name":"National Centre for Infection in Cancer Peter MacCallum Cancer Centre  Melbourne Victoria Australia"},{"name":"Vaccine and Infectious Diseases Division Fred Hutchinson Cancer Center  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Yeoh","sequence":"additional","affiliation":[{"name":"National Centre for Infection in Cancer Peter MacCallum Cancer Centre  Melbourne Victoria Australia"},{"name":"Department of Infectious Diseases Perth Children's Hospital  Perth Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin W.","family":"Teh","sequence":"additional","affiliation":[{"name":"National Centre for Infection in Cancer Peter MacCallum Cancer Centre  Melbourne Victoria Australia"},{"name":"Sir Peter MacCallum Department of Oncology University of Melbourne  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma K.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"National Centre for Infection in Cancer Peter MacCallum Cancer Centre  Melbourne Victoria Australia"},{"name":"Sir Peter MacCallum Department of Oncology University of Melbourne  Melbourne Victoria Australia"},{"name":"Department of Infectious Diseases Austin Health  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Henden","sequence":"additional","affiliation":[{"name":"Cancer Care Services Royal Brisbane and Women's Hospital  Brisbane Queensland Australia"},{"name":"Translational Cancer Immunotherapy Laboratory QIMR Berghofer Medical Research Institute  Brisbane Queensland Australia"},{"name":"Faculty of Medicine University of Queensland  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"McQuilten","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University and Department of Haematology Monash Health, Melbourne  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Tauranga Hospital Te Whatu ora \u2010 Hauora a Toi  New Zealand"},{"name":"University of Auckland  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology University of Melbourne  Melbourne Victoria Australia"},{"name":"Department of Medical Oncology Peter MacCallum Cancer Centre  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Nelson","sequence":"additional","affiliation":[{"name":"Kids Cancer Centre Sydney Children's Hospital  Australia"},{"name":"Discipline of Paediatrics and Child Health, School of Clinical Medicine University of New South Wales  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Nakagaki","sequence":"additional","affiliation":[{"name":"Pharmacy Department Royal Brisbane and Women's Hospital  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahneen","family":"Sandhu","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology University of Melbourne  Melbourne Victoria Australia"},{"name":"Department of Medical Oncology Peter MacCallum Cancer Centre  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[{"name":"National Centre for Infection in Cancer Peter MacCallum Cancer Centre  Melbourne Victoria Australia"},{"name":"Sir Peter MacCallum Department of Oncology University of Melbourne  Melbourne Victoria Australia"},{"name":"Department of Infectious Diseases Peter MacCallum Cancer Centre  Melbourne Australia"},{"name":"Department of Infectious Diseases University of Melbourne  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Australasian Neutropenic Fever Guidelines Steering Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,1,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2010.02341.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00374"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5368"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04452-9"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04297-8"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30725-7"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2018-000355"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2395"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad1329"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.3747\/co.26.5177"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900623"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01702-9"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.706331"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis580"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.01.030"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.3348"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2020.10.012"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005129"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33030"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3400"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003369"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2311"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ137"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85946-4"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.70249"},{"key":"e_1_2_8_27_1","unstructured":"European Medicines Agency.Systemic and inhaled fluoroquinolones: risk of heart valve regurgitation\/incompetence 2020. Available from URL: ema.europa.eu."},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.2165\/11593110-000000000-00000"},{"key":"e_1_2_8_29_1","unstructured":"U.S Food and Drug Administration.Fluoroquinolone Antimicrobial Drugs Information2023. Available from URL:fda.gov."},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030804"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21847"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182307e3c"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.10.009"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.124"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30506-6"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044097"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050078"},{"key":"e_1_2_8_38_1","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter\u2010Gvili A","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01474"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000687"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.70248"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.07.019"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29835"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.70251"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac240"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.527408"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.518655"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0006"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1008.020694"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy825"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix646"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02494-19"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1086\/496986"},{"key":"e_1_2_8_54_1","first-page":"001122","article-title":"The clinical, genomic, and microbiological profile of invasive multi\u2010drug resistant Escherichia coli in a major teaching hospital in the United Kingdom","volume":"9","author":"Hamilton WL","year":"2023","journal-title":"Microb Genom"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.12.006"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008226"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.08.001"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13225"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13670"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1488252"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab404"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12345"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30824-1"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008073"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-022-00001-9"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00425-3"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1361028"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010539"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203478"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012971"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01632"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614359"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.0771"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00335-7"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01556-7"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902688"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007233"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-869453"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01786-9"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2020.1843752"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26771"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30525-8"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204591"},{"key":"e_1_2_8_84_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206913"},{"key":"e_1_2_8_85_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01725"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00889-8"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009435"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00159-6"},{"key":"e_1_2_8_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.07.011"},{"key":"e_1_2_8_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00879-7"},{"key":"e_1_2_8_91_1","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211036773"},{"key":"e_1_2_8_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.104134"},{"key":"e_1_2_8_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-94353-0"},{"key":"e_1_2_8_94_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.229781"},{"key":"e_1_2_8_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01521-5"},{"key":"e_1_2_8_96_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004000"},{"key":"e_1_2_8_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01756-w"},{"key":"e_1_2_8_98_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1881506"},{"key":"e_1_2_8_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002732"},{"key":"e_1_2_8_100_1","volume-title":"Open Forum Infectious Diseases","author":"Vora SB","year":"2020"},{"key":"e_1_2_8_101_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy152"},{"key":"e_1_2_8_102_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071684"},{"key":"e_1_2_8_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00346-7"},{"key":"e_1_2_8_104_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-793760"},{"key":"e_1_2_8_105_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.238634"},{"key":"e_1_2_8_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13712"},{"key":"e_1_2_8_107_1","doi-asserted-by":"publisher","DOI":"10.21037\/sci-2021-008"},{"key":"e_1_2_8_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004896"},{"key":"e_1_2_8_109_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01467"},{"key":"e_1_2_8_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.10.005"},{"key":"e_1_2_8_111_1","article-title":"Real\u2010world data from kings college hospital: infection complications post CAR\u2010T treatment in high\u2010grade B cell non\u2010hodgkin lymphoma","volume":"55","author":"Wong SM","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_8_112_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.7545"},{"key":"e_1_2_8_113_1","doi-asserted-by":"publisher","DOI":"10.1177\/09636897211025503"},{"key":"e_1_2_8_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12260"},{"key":"e_1_2_8_115_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004475"},{"key":"e_1_2_8_116_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010543"},{"key":"e_1_2_8_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.05.011"},{"key":"e_1_2_8_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27056"},{"key":"e_1_2_8_119_1","unstructured":"ClinicalTrials.gov.A Trial of Pembrolizumab (MK\u20103475) in Participants With Blood Cancers (MK\u20103475\u2010013\/ KEYNOTE\u2010013)2021. Available from URL:https:\/\/clinicaltrials.gov\/study\/NCT01953692."},{"key":"e_1_2_8_120_1","unstructured":"ClinicalTrials.gov.Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) (CheckMate 205): U.S. Department of Health and Human Services;2023Available from URL:https:\/\/clinicaltrials.gov\/study\/NCT02181738."},{"key":"e_1_2_8_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00377-8"},{"key":"e_1_2_8_122_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1082"},{"key":"e_1_2_8_123_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e31822817a6"},{"key":"e_1_2_8_124_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac594"},{"key":"e_1_2_8_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcsup.2007.06.002"},{"key":"e_1_2_8_126_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir073"},{"key":"e_1_2_8_127_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0093"},{"key":"e_1_2_8_128_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.8661"},{"key":"e_1_2_8_129_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw325"},{"key":"e_1_2_8_130_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182793610"},{"key":"e_1_2_8_131_1","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S33906"},{"key":"e_1_2_8_132_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.12512"},{"key":"e_1_2_8_133_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piad041"},{"key":"e_1_2_8_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30202-0"},{"key":"e_1_2_8_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.12.012"},{"key":"e_1_2_8_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.11.017"},{"key":"e_1_2_8_137_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix644"},{"key":"e_1_2_8_138_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2023.2171987"},{"key":"e_1_2_8_139_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/150.3.372"},{"key":"e_1_2_8_140_1","first-page":"1441","article-title":"Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study","volume":"69","author":"Preisler H","year":"1987","journal-title":"Blood"},{"key":"e_1_2_8_141_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12599"},{"key":"e_1_2_8_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2017.10.009"},{"key":"e_1_2_8_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1698-0"},{"key":"e_1_2_8_144_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-6-200709180-00010"},{"key":"e_1_2_8_145_1","unstructured":"National Comprehensive Cancer Network.Prevention and Treatment of Cancer\u2010Related Infections 2023[cited 2025 Feb 11]; Available from URL:https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/infections.pdf."},{"key":"e_1_2_8_146_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.3488"},{"key":"e_1_2_8_147_1","article-title":"Primary prophylactic colony\u2010stimulating factors for the prevention of chemotherapy\u2010induced febrile neutropenia in breast cancer patients","volume":"10","author":"Renner P","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_148_1","article-title":"Colony\u2010stimulating factors for chemotherapy\u2010induced febrile neutropenia","volume":"2014","author":"Mhaskar R","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_149_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14082"},{"key":"e_1_2_8_150_1","unstructured":"UK DoH.NHS England updated commissioning criteria for the use of therapeutic immunoglobulin (Ig) in immunology haematology neurology and infectious diseases in England. January 2019. Available from URL:http:\/\/igd.mdsas.com\/wp-content\/uploads\/Ig-PWG-Guidance-for-the-use-of-Ig-V1.3-12022019.pdf."},{"key":"e_1_2_8_151_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008073"},{"key":"e_1_2_8_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.003"},{"key":"e_1_2_8_153_1","unstructured":"CentreFHC.Immunotherapy (IMTX): Vaccination after B cell\u2010targeted CAR\u2010T cell therapy for Adult and Pediatric Immune Effector Cell (IEC) Patients"},{"key":"e_1_2_8_154_1","unstructured":"The Department of Health and Aged Care.Australian Immunisation Handbook: Vaccination for people who are immunocompromised 2023. Available from URL:immunisationhandbook.health.gov.au."},{"key":"e_1_2_8_155_1","first-page":"1345","article-title":"Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G\u2010CSF) in patients receiving docetaxel\u2010cyclophosphamide chemotherapy for breast cancer (REaCT\u2010TC)","volume":"27","author":"Clemons M","year":"2019","journal-title":"Support Care Cancer"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.70250","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/imj.70250","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.70250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:24:49Z","timestamp":1783956289000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.70250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":154,"journal-issue":{"issue":"S7","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1111\/imj.70250"],"URL":"https:\/\/doi.org\/10.1111\/imj.70250","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"2025-10-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}